CHENG Lenan, GE Licong, LU Xiaoli, LI Ning, YANG Qiuyun. Observation on efficacy of 5-aminolevulinic acid photodynamic therapy for low-grade squamous intraepithelial lesion with high-risk human papillomavirus infection[J]. Journal of Clinical Medicine in Practice, 2021, 25(6): 20-24. DOI: 10.7619/jcmp.20201114
Citation: CHENG Lenan, GE Licong, LU Xiaoli, LI Ning, YANG Qiuyun. Observation on efficacy of 5-aminolevulinic acid photodynamic therapy for low-grade squamous intraepithelial lesion with high-risk human papillomavirus infection[J]. Journal of Clinical Medicine in Practice, 2021, 25(6): 20-24. DOI: 10.7619/jcmp.20201114

Observation on efficacy of 5-aminolevulinic acid photodynamic therapy for low-grade squamous intraepithelial lesion with high-risk human papillomavirus infection

More Information
  • Received Date: October 13, 2020
  • Available Online: April 08, 2021
  • Published Date: March 27, 2021
  •   Objective  To investigate the clinical efficacy and safety of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) in the treatment of low-grade cervical squamous intraepithelial lesion (LSIL) patients with high-risk human papillomavirus (HR-HPV) infection.
      Methods  A total of 60 LSIL patients with HR-HPV infection were divided into control group and observation group according to random number table method, with 30 cases in each group. The control group was treated with routine medicine, while the observation group was treated with ALA-PDT. The treatment effects, the clearance rate of HPV, the scores of Self-rating Anxiety Scale(SAS) and Self-rating Depression Scale (SDS) were compared between the two groups.
      Results  Six months after treatment, the total effective rate of the observation group was 83.33%, which was significantly higher than 53.33% in the control group(P < 0.05). The clearance rate of HR-HPV in the observation group was significantly higher than that in the control group (P < 0.05). There were no significant differences in SAS and SDS scores between the two groups before treatment(P>0.05). After treatment, SAS and SDS scores in the observation group were significantly lower than those the control group(P < 0.05). No obvious adverse reactions occurred in the two groups.
      Conclusion  ALA-PDT is a safe and effective method in the treatment of LSIL with HR-HPV infection, and can improve status of anxiety and depression of patients.
  • [1]
    TSIKOURAS P, ZERVOUDIS S, MANAV B, et al. Cervical cancer: Screening, diagnosis and staging[J]. Journal of Buon, 2016, 21(2): 320-325. http://www.ncbi.nlm.nih.gov/pubmed/27273940
    [2]
    HELLNER K, DORRELL L. Recent advances in understanding and preventing human papillomavirus-related disease[J]. F1000 Res, 2017, 6: F1000 Faculty Rev-269. doi: 10.12688/f1000research.11587.1
    [3]
    KURMAN R J, CARCANGIU M L, HERRINGTON C S, et al. WHO classification of tumours of female reproductive organs[M]. 4th Edition. Lyon: IARC, 2014: 172-176, 183-184.
    [4]
    党敏玲, 王彩娥, 倚西红. 低级别宫颈上皮内病变患者40例治疗及随访[J]. 实用临床医药杂志, 2017, 21(21): 225-227. doi: 10.7619/jcmp.201721094
    [5]
    李瑞, 刘莉娜, 陈立达. 氨乙酰丙酸介导的光动力疗法对宫颈人乳头瘤病毒感染合并宫颈上皮内瘤变的疗效影响[J]. 实用临床医药杂志, 2019, 23(11): 63-65, 69. doi: 10.7619/jcmp.201911018
    [6]
    张韶凯, 赵方辉, 乔友林. 中国宫颈癌防治研究20年历程与成就[J]. 中华流行病学杂志, 2020, 41(6): 809-812.
    [7]
    WANG J, ELFSTRñM K M, Andrae B, et al. Cervical cancer case-control audit: Results from routine evaluation of a nationwide cervical screening program[J]. Int J Cancer, 2020, 146(5): 1230-1240. doi: 10.1002/ijc.32416
    [8]
    魏丽惠, 沈丹华, 赵方辉, 等. 中国子宫颈癌筛查及异常管理相关问题专家共识(二)[J]. 中国妇产科临床杂志, 2017, 18(3): 286-288. https://www.cnki.com.cn/Article/CJFDTOTAL-FKLC201703043.htm
    [9]
    李明珠, 赵昀, 李静然, 等. 2019 ASCCP基于风险的子宫颈癌筛查结果异常的管理共识解读[J]. 中国妇产科临床杂志, 2020, 21(4): 446-448. https://www.cnki.com.cn/Article/CJFDTOTAL-FKLC202004036.htm
    [10]
    丁阳, 卢建军. 宫颈锥切术对妊娠结局影响的研究进展[J]. 中国实用医刊, 2020(15): 119-122. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201416028.htm
    [11]
    SOERGEL P, WANG X, STEPP H, et al. Photodynamic therapy of cervical intraepithelial neoplasia with hexaminolevulinate[J]. Lasers Surg Med, 2008, 40(9): 611-615. doi: 10.1002/lsm.20686
    [12]
    苏小玉, 蒙莉萍, 邹聪聪, 等. 重组人干扰素凝胶联合保妇康栓治疗宫颈高危型HPV感染的临床观察[J]. 中国药房, 2020, 31(8): 984-988. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYA202008016.htm
    [13]
    徐永娟, 陈昕华, 叶文凤. 冷冻联合重组人干扰素α-2b栓治疗宫颈低级别鳞状上皮内病变的效果探究[J]. 中国继续医学教育, 2017, 9(20): 164-165. https://www.cnki.com.cn/Article/CJFDTOTAL-JXUY201720101.htm
    [14]
    王燕婷, 陈丽影, 周益美. 加味二妙散联合重组人干扰素α2b治疗低级别宫颈鳞状上皮内病变临床观察[J]. 中外医学研究, 2019, 17(29): 28-30. https://www.cnki.com.cn/Article/CJFDTOTAL-YJZY201929012.htm
    [15]
    林杏娟, 肖文平, 麦健敏. 重组人干扰素α-2b栓联合物理治疗宫颈上皮内瘤变Ⅰ级合并高危HPV阳性疗效观察[J]. 中国处方药, 2020, 18(2): 108-109. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCF202002065.htm
    [16]
    GUO X, QIU L, WANG Y, et al. A randomized open-label clinical trial of an anti-HPV biological dressing(JB01-BD)administered intravaginally to treat high-risk HPV infection[J]. Microbes Infec, 2016, 18(2): 148-152. http://www.sciencedirect.com/science/article/pii/S1286457915002270
    [17]
    傅裕, 鲍迎秋, 朝鲁, 等. 5-氨基酮戊酸光动力疗法治疗宫颈高危型人乳头瘤病毒感染疗效分析[J]. 临床军医杂志, 2018, 46(7): 752-754. https://www.cnki.com.cn/Article/CJFDTOTAL-JYGZ201807006.htm
    [18]
    HILLEMANNS P, PETRY K U, SOERGEL P, et al. Efficacy and safety of hexaminolevulinate photodynamic therapy in patients with low-grade cervical intraepithelial neoplasia[J]. Lasers Surg Med, 2014, 46(6): 456-461. doi: 10.1002/lsm.22255
    [19]
    黄舒婷, 左帆, 刘雯雯, 等. 5-氨基酮戊酸光动力治疗16型或(和)18型人乳头状瘤病毒宫颈持续感染合并宫颈低级别上皮内瘤样病变疗效观察[J]. 妇产与遗传: 电子版, 2020, 10(3): 17-21.
  • Cited by

    Periodical cited type(11)

    1. 高书红,王正芳,姚丽文,刘兴祥,崔林. 集束化护理在光动力治疗复发性梗阻性食管癌中的应用效果. 实用临床医药杂志. 2025(02): 129-132 . 本站查看
    2. 林黎莉,赵周英. HPV感染患者SIL临床分级与HPV分型关系. 中国计划生育学杂志. 2024(05): 1148-1152 .
    3. 李国敏. 二氧化碳激光联合干扰素治疗宫颈低级别上皮内病变伴高危型人乳头瘤病毒感染患者的效果探究. 中国实用医药. 2024(16): 39-43 .
    4. 迟亚松,岳瑞芹,吕艳茹,李海燕,廖伟. 重组人干扰素α-2b凝胶联合匹多莫德治疗宫颈低级别鳞状上皮内病变的临床研究. 中国现代医学杂志. 2024(23): 74-79 .
    5. 刘晓璐. 循证护理结合5-氨基酮戊酸光动力疗法对尖锐湿疣患者的效果分析. 黑龙江医药科学. 2023(01): 105-106 .
    6. 王红波. 阴道镜下宫颈环形电切术治疗宫颈低级别鳞状上皮内病变患者的临床效果. 婚育与健康. 2023(04): 16-18 .
    7. 卞干霞,李洁华,周丹丹,薛金玲. 光动力治疗子宫切除术后阴道上皮内瘤变的临床疗效及安全性观察. 实用妇科内分泌电子杂志. 2023(02): 7-9 .
    8. 胡春涛. 激光治疗联合重组人干扰素治疗宫颈低级别鳞状上皮内病变的临床效果分析. 智慧健康. 2023(13): 134-138 .
    9. 高宁淳. 聚焦超声用于轻度宫颈上皮内瘤变治疗的临床研究. 系统医学. 2022(01): 168-172 .
    10. 黄水兰,周潇妮,王晓晖,邓文,胡凯,胡岗. 保妇康栓联合干扰素α2b治疗子宫颈HPV感染患者的临床价值系统分析. 中国医学创新. 2022(32): 138-144 .
    11. 周妍,孙静莉,张晓梅. 5-氨基酮戊酸光动力疗法治疗阴道上皮内瘤变临床疗效. 创伤与急危重病医学. 2021(06): 474-476 .

    Other cited types(1)

Catalog

    Article views (365) PDF downloads (32) Cited by(12)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return